Adstiladrin
Payments companies reported to CMS as associated with Adstiladrin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Adstiladrin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Adstiladrin
These are the largest totals companies reported as associated with Adstiladrin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Grannum Sant | Bridgewater, NJ | Urology | $472,172.12 |
| Gautam Jayram | Nashville, TN | Urology | $134,256.60 |
| Ravi Chauhan | Germantown, TN | Urology | $123,025.60 |
| Chinedu Mmeje | Gilbert, AZ | Urology | $100,551.52 |
| Chad Reichard | Carmel, IN | Urology | $99,405.53 |
| Piyush Agarwal | Chicago, IL | Urology | $90,564.44 |
| Lawrence Karsh | Denver, CO | Urology | $80,226.09 |
| Katie Murray | New York, NY | Urology | $77,923.18 |
| Michael Williams | Virginia Beach, VA | Urology | $69,096.03 |
| Aaron Berger | Chicago Ridge, IL | Urology | $41,985.81 |
Prescribed Adstiladrin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.